GINKGO-1A Pharma 40 mg film -coated tablets, 120 pcs

Instructions for use for GINKGO-1A Pharma 40 mg film -coated tablets, 120 pcs

Field of use

• The medicine contains an extract made of ginkgo leaves.
• It is used:
  • a) For the symptomatic treatment of braingian -related mental performance losses in the context of an overall therapeutic concept when accepted or loss of acquired mental abilities (dementia syndromes) with the main problems: memory disorders, concentration disorders, lowness, dizziness, ears, headaches.
    • The individual response to the medication cannot be predicted.
    • Before the treatment begins with this medicine, it should be clarified whether the disease signs are not based on a specifically treated underlying disease.
  • b) To extend the pain -free walking distance in the case of arterial closure disease in the limbs, so -called "shop window disease" (Claudicatio intermitters in stage II according to Fontaine) in the context of physical therapeutic measures, in particular walking training.
  • c) in the event of dizziness as a result of circulatory disorders or age -related regression (Vertigo vascular and involved). For the supportive treatment of ear noises as a result of circulatory disorders or age -related regression (tinnitus of vascular and involved genesis).
    • Frequently occurring dizziness and ears of the ears basically need to clarify by a doctor. In the event of sudden hearing loss or hearing loss, a doctor should be consulted immediately.

Active ingredients / ingredients / ingredients

40 mg ginkgo leaves dry extract, (35-67: 1), extractor: acetone 60% (m/m)
Ginkgo flavonoid glycosides
Ginkgolide A+B+C
Bilobalide
Ginkgolic acids
Carboxymethylar, sodium salt auxiliary material (+)
Cellulose, microcrystalline auxiliary material (+)
Iron (III) hydroxide oxide x-water Hedge substance (+)
Glucose syrup auxiliary substance (+)
Hypromellic auxiliary substance (+)
Lactose 1-water auxiliary substance (+)
Macrogol 4000 auxiliary substances (+)
Magnesium stair (Ph. EUR.) [pflanzlich] Hedge substance (+)
Corn starch auxiliary substance (+)
Silicium dioxide, high disperser auxiliary substance (+)
Titan dioxide HILDBOFT (+)
0.02 Be total carbohydrates Hedge substance (+)
23 mg total sodium ion hedge material (+)
Total sodium ion helper (+)

Contradictions

• The medicine must not be taken
  • if you are allergic to Ginkgo Biloba or one of the other components of this medicine
  • during pregnancy.

dosage

• Always take the preparation exactly as described or follow your doctor or pharmacist.
• Ask your doctor or pharmacist if you are not sure.
• The recommended dose is:
  • a) For the symptomatic treatment of braingian -related mental performance losses, adults from the age of 18 should take 1 - 2 film -coated tablets 3 times a day (corresponding to 120 - 240 mg GinkGO extract per day).
  • b) To extend the pain -free walking distance with arterial closure disease in the limbs, adults from the age of 18 should take 1 1/2 - 2 film -coated tablets twice a day (corresponding to 120 - 160 mg GinkGO extract per day).
  • c) In the event of dizziness and for supporting treatment for ear noise, adults from the age of 18 should take 1 1/2 - 2 film -coated tablets twice a day (corresponding to 120 - 160 mg GinkGO extract per day).
• Children and adolescents
  • The medicine is not intended for use in children and adolescents under the age of 18.

 

• Duration of the application
  • In mental loss of performance in brainganic
    • The duration of treatment should be at least 8 weeks. After a treatment period of 3 months, the doctor must check whether the continuation of the treatment is still justified.
  • In the case of arterial closure disease in the limbs
    • An improvement in walking performance sets a treatment duration of at least 6 weeks ahead.
  • With dizziness
    • The application over a longer period of time than 6-8 weeks does not improve the result of the treatment.
  • With ear noise
    • Supporting treatment should take place over a period of at least 12 weeks. If no success has occurred after 6 months, it can no longer be expected even during longer treatment.
• Please speak to your doctor or pharmacist if you have the impression that the effect is too strong or too weak.

 

 

• If you have taken a larger amount than you should
  • Overdose symptoms are not yet known. The side effects listed below may occur increased; In this case, please notify a doctor. This may decide on the necessary measures.

 

• If you have forgotten the intake
  • Do not take the twice the amount, but continue with taking it, as prescribed by your doctor or described in the use information.

 

• If you have any further questions about taking this medicine, please contact your doctor or pharmacist.

Taking

• To take. Do not take film -coated tablets while lying down.
• Take in the film -coated clay with sufficient liquid (preferably 1 glass of drinking water).
• The application takes place in the morning, at lunch and evening, with 2 times daily application in the morning and in the evening.
• The intake can take place independently of the meals.
• The tablet can be divided into the same doses. To divide, put the tablet with the Bruchkerbe up on a fixed surface. With slight pressure with the thumb you halve the tablet.

Patient information

• Warnings and Precautions
  • Please speak to your doctor or pharmacist before taking the preparation.
  • In the event of pathologically increased bleeding (hemorrhagic diathesis) as well as at the same time treatment with anticoagulant medicines or platelet aggregation inhibitors, this medicine should only be used after consultation with a doctor.
  • Since there are individual indications that ginkgo-containing preparations could increase the willingness to bleed, this medicine should be deducted 3 to 4 days before surgery as a precaution.
  • If you are known to an anti -Kramplepse (epilepsy), please consult your doctor or pharmacist before taking it.
  • The simultaneous intake of Ginkgo Biloba-Paepparaten and Efavirenz is not recommended.
  • Children and adolescents
    • There is no sufficient investigations to apply this drug in this age group. It should therefore not be used in children and adolescents under the age of 18.

 

• Wateriness and ability to operate machines
  • There was no sufficient studies on the effects on the traffic and the ability to use machines.

Pregnancy

• If you are pregnant or breastfeed, or if you suspect that you are pregnant or intend to become pregnant, ask your doctor or pharmacist for advice before taking this drug.
• Pregnancy
  • Since there are individual indications that ginkgo-containing preparations can increase the willingness to bleed, this medicine must not be taken during pregnancy.
• Breastfeeding
  • This medicine should not be used during breastfeeding because there is no sufficient examinations. It is not known whether ingredients of the extract change into breast milk.

Hints

Manufacturer:  1 A Pharma GmbH, Keltenring 1+3, 82041 Oberhaching